AA, S., E, P., E, K., I, G., & F, Z. (2026). Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases. Current oncology reports, 28(1), . https://doi.org/10.1007/s11912-026-01806-2
Chicago Style (17th ed.) CitationAA, Sofianidi, Panagodimou E, Kalampokas E, Georgakopoulos I, and Zagouri F. "Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases." Current Oncology Reports 28, no. 1 (2026). https://doi.org/10.1007/s11912-026-01806-2.
MLA (9th ed.) CitationAA, Sofianidi, et al. "Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases." Current Oncology Reports, vol. 28, no. 1, 2026, https://doi.org/10.1007/s11912-026-01806-2.
Warning: These citations may not always be 100% accurate.